Silicon Laboratories Inc.
Cash Flow Statement
| Line Item | FY2026 | FY2024 | FY2023 | FY2022 | FY2021 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-64.9M | $-191.0M | $-34.5M | $91.4M | $12.5M | $19.3M | $83.6M | $47.1M |
| Depreciation & Amortization | — | — | — | — | — | — | — | — |
| Depreciation | $24.7M | $25.6M | $25.7M | $22.5M | $16.3M | $15.2M | $15.9M | $14.8M |
| Amortization | $13.4M | $23.0M | $25.4M | $34.1M | $42.6M | $37.7M | $38.0M | $27.1M |
| Stock-Based Compensation | $80.3M | $61.5M | $48.2M | $60.5M | $49.5M | $44.3M | $50.1M | $44.8M |
| Net Cash from Operating Activities | $95.7M | $-13.9M | $-30.3M | $141.3M | $135.7M | $166.5M | $173.5M | $189.5M |
| Investing Activities | ||||||||
| Capital Expenditures | $29.9M | $11.7M | $22.3M | $26.5M | $18.1M | $15.3M | $24.5M | $12.3M |
| Business Acquisitions | — | — | — | — | $316.8M | $2.5M | $239.7M | $15.2M |
| Net Cash from Investing Activities | $-12.0M | $113.1M | $469.8M | $240.5M | $-361.0M | $-106.8M | $-197.0M | $-374.3M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $0 | $16.0K | $217.1M | $883.4M | $16.3M | $26.7M | $39.3M | — |
| Net Cash from Financing Activities | $-1.1M | $-45.1M | $-711.9M | $-887.1M | $200.9M | $-29.6M | $-48.8M | $313.0M |
| Net Change in Cash | $82.6M | $54.1M | $-272.4M | $-574.7M | $-24.4M | $30.1M | $-72.3M | $128.3M |
| Free Cash Flow | $65.8M | $-25.7M | $-52.6M | $114.7M | $117.6M | $151.2M | $149.1M | $177.3M |